Skip to main content
SpringerLink
Log in

Palliative Care in Cirrhosis

  • Chapter
  • First Online:
Complications of Cirrhosis

  • 1971 Accesses

Abstract

The families and patients with end-stage liver disease (ESLD) confront physical and emotional challenges that are not frequently addressed by health-care providers. Palliative care emphasizes the assessment, anticipation, and alleviation of suffering in patients dying from the complications of cirrhosis in a holistic, patient-centered and family-focused manner. This chapter reviews the application of palliative care principles to patients with ESLD and the management of specific complications in the terminally ill patient.

“May I never see in the patient anything but a fellow creature in pain” Maimonides

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–31.

    Article  PubMed  Google Scholar 

  2. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on chronic liver failure is a distinct syndrome that develops in patients with acute decompenstation of cirrhosis. Gastroenterology. 2013;144(7):1426–37.

    Article  PubMed  Google Scholar 

  3. Martin P, DiMartini A, Feng S, Brown R, Jr., Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59(3):1144–65.

    Article  PubMed  Google Scholar 

  4. OPTN & SRTR Annual Data Report. Available at http://www.srtr.org. Accessed 14 March 2014.

  5. Shawcross DL, Austin MJ, Abeles RD, McPhail MJ, Yeoman AD, Taylor NJ, et al. The impact of organ dysfunction in cirrhosis: survival at a cost? J Hepatol. 2012;56(5):1054–62.

    Article  PubMed  Google Scholar 

  6. Meier DE. Increased access to palliative care and hospice services: opportunities to improve value in health care. Milbank Q. 2011 Sep;89(3):343–80.

    Article  PubMed Central  PubMed  Google Scholar 

  7. World Health Organization. WHO Definition of Palliative Care; 2014. http://www.who.int/cancer/palliative/definition/en/. Access 15 March 2014.

  8. Roth K, Lynn J, Zhong Z, Borum M, Dawson NV. Dying with end stage liver disease with cirrhosis: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatment. J Am Geriatr Soc. 2000;48(5 Suppl):S122–30.

    CAS  PubMed  Google Scholar 

  9. Walling AM, Asch SM, Lorenz KA, Wenger NS. Impact of consideration of transplantation on end-of-life care for patients during a terminal hospitalization. Transplantation. 2013;95(4):641–6.

    Article  PubMed  Google Scholar 

  10. Poonja Z, Brisebois A, van Zanten SV, Tandon P, Meeberg G, Karvellas CJ. Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clin Gastroenterol Hepatol: 2014;12(4):692–8.

    Article  Google Scholar 

  11. Walling AM, Wenger NS. Palliative care and end-stage liver disease. Clin Gastroenterol Hepatol: 2014;12(4):699–700.

    Article  Google Scholar 

  12. Salpeter SR, Luo EJ, Malter DS, Stuart B. Systematic review of noncancer presentations with a median survival of 6 months or less. Am J Med. 2012;125(5):512. e1–6.

    Article  PubMed  Google Scholar 

  13. Medici V, Rossaro L, Wegelin JA, Kamboj A, Nakai J, Fisher K, et al. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Liver Transplant: 2008;14(8):1100–6.

    Article  Google Scholar 

  14. The National Consensus Project for Quality Palliative Care Clinical Practice Guidelines for Quality Palliative Care. 3rd edition; 2013. http://www.nationalconsensusproject.org/NCP_Clinical_Practice_Guidelines_3rd_Edition.pdf. Accessed 15 March 2014.

  15. Quill TE, Abernethy AP. Generalist plus specialist palliative care—creating a more sustainable model. N Engl J Med. 2013;368(13):1173–5.

    Article  CAS  PubMed  Google Scholar 

  16. Ogle K, Thompson ME, Noel MM. The web-based worksheet: an opportunity for prompt, consistent, and expert feedback in a community-based hospice experience. J Palliat Med. 2002;5(5):756–7.

    Article  PubMed  Google Scholar 

  17. Martin WE, Miller SC, Welch LC, Burrill J. Improving access to hospice: the Physician Feedback and Reminders to Improve Access to Hospice (PFRIAH) study. Med Health R I. 2007;90(12):388–90.

    PubMed  Google Scholar 

  18. Gazelle G. Understanding hospice—an underutilized option for life's final chapter. N Engl J Med. 2007;357(4):321–4.

    Article  CAS  PubMed  Google Scholar 

  19. Larson AM, Curtis JR. Integrating palliative care for liver transplant candidates: “too well for transplant, too sick for life”. JAMA. 2006;295(18):2168–76.

    Article  CAS  PubMed  Google Scholar 

  20. Hope AA, Morrison RS. Integrating palliative care with chronic liver disease care. J Palliat Care. 2011;27(1):20–7.

    PubMed  Google Scholar 

  21. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42.

    Article  CAS  PubMed  Google Scholar 

  22. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087–107.

    Article  PubMed  Google Scholar 

  23. Planas R, Montoliu S, Balleste B, Rivera M, Miquel M, Masnou H, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol: 2006;4(11):1385–94.

    Article  Google Scholar 

  24. EASL. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397–417.

    Article  Google Scholar 

  25. Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57(4):1651–3.

    Article  PubMed  Google Scholar 

  26. Wong F, Watson H, Gerbes A, Vilstrup H, Badalamenti S, Bernardi M, et al. Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity. Gut. 2012;61(1):108–16.

    Article  CAS  PubMed  Google Scholar 

  27. Serste T, Francoz C, Durand F, Rautou PE, Melot C, Valla D, et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. J Hepatol. 2011;55(4):794–9.

    Article  CAS  PubMed  Google Scholar 

  28. Serste T, Melot C, Francoz C, Durand F, Rautou PE, Valla D, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52(3):1017–22.

    Article  CAS  PubMed  Google Scholar 

  29. Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al. The North American study for the treatment of refractory ascites. Gastroenterology. 2003;124(3):634–41.

    Article  PubMed  Google Scholar 

  30. Zervos EE, McCormick J, Goode SE, Rosemurgy AS. Peritoneovenous shunts in patients with intractable ascites: palliation at what price? Am Surg. 1997;63(2):157–62.

    CAS  PubMed  Google Scholar 

  31. Reisfield GM, Wilson GR. Management of intractable, cirrhotic ascites with an indwelling drainage catheter. J Palliat Med. 2003;6(5):787–91.

    Article  PubMed  Google Scholar 

  32. Lungren MP, Kim CY, Stewart JK, Smith TP, Miller MJ. Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. J Vasc Interv Radiol. 2013;24(9):1303–8.

    Article  PubMed  Google Scholar 

  33. Coupe NA, Cox K, Clark K, Boyer M, Stockler M. Outcomes of permanent peritoneal ports for the management of recurrent malignant ascites. J Palliat Med. 2013;16(8):938–40.

    Article  PubMed  Google Scholar 

  34. Savin MA, Kirsch MJ, Romano WJ, Wang SK, Arpasi PJ, Mazon CD. Peritoneal ports for treatment of intractable ascites. J Vasc Interv Radiol. 2005;16(3):363–8.

    Article  PubMed  Google Scholar 

  35. Bellot P, Welker MW, Soriano G, von Schaewen M, Appenrodt B, Wiest R, et al. Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. J Hepatol. 2013;58(5):922–7.

    Article  PubMed  Google Scholar 

  36. Mercky P, Sakr L, Heyries L, Lagrange X, Sahel J, Dutau H. Use of a tunnelled pleural catheter for the management of refractory hepatic hydrothorax: a new therapeutic option. Respiration. 2010;80(4):348–52.

    Article  PubMed  Google Scholar 

  37. Garcia N, Jr., Mihas AA. Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol. 2004;38(1):52–8.

    Article  PubMed  Google Scholar 

  38. Alonso JC. Pleural effusion in liver disease. Semin Respir Crit Care Med. 2010;31(6):698–705.

    Article  PubMed  Google Scholar 

  39. Gordon FD, Anastopoulos HT, Crenshaw W, Gilchrist B, McEniff N, Falchuk KR, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology. 1997;25(6):1366–9.

    Article  CAS  PubMed  Google Scholar 

  40. Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol. 2001;13(5):529–34.

    Article  CAS  PubMed  Google Scholar 

  41. Milanez de Campos JR, Filho LO, de Campos Werebe E, Sette H Jr, Fernandez A, Filomeno LT, et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest. 2000;118(1):13–7.

    Article  CAS  PubMed  Google Scholar 

  42. Orman ES, Lok AS. Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int. 2009;3(4):582–6.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129(2):362–8.

    Article  PubMed  Google Scholar 

  44. Bhatnagar R, Reid ED, Corcoran JP, Bagenal JD, Pope S, Clive AO, et al. Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice. Thorax 2014 (printed);69(10):959-61(online).

    Google Scholar 

  45. Murthy SC, Okereke I, Mason DP, Rice TW. A simple solution for complicated pleural effusions. J Thorac Oncol. 2006;1(7):697–700.

    Article  PubMed  Google Scholar 

  46. Rahimi RS, Rockey DC. Hepatic encephalopathy: how to test and treat. Curr Opin Gastroenterol. 2014;30(3):265–71.

    Article  PubMed  Google Scholar 

  47. Strauss E, Tramote R, Silva EP, Caly WR, Honain NZ, Maffei RA, et al. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepatogastroenterology. 1992;39(6):542–5.

    CAS  PubMed  Google Scholar 

  48. Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013;108(9):1458–63.

    Article  CAS  PubMed  Google Scholar 

  49. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118–27.

    Article  CAS  PubMed  Google Scholar 

  50. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.

    Article  PubMed Central  PubMed  Google Scholar 

  51. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–43.

    Article  Google Scholar 

  52. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤ 4 cm. Gastroenterology. 2004;127(6):1714–23.

    Article  PubMed  Google Scholar 

  53. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47(1):82–9.

    Article  PubMed  Google Scholar 

  54. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer. 2005;103(6):1201–9.

    Article  PubMed  Google Scholar 

  55. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 2003;37(2):429–42.

    Article  CAS  PubMed  Google Scholar 

  56. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–90.

    Article  CAS  PubMed  Google Scholar 

  57. Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther. 2003;17(7):857–70.

    Article  CAS  PubMed  Google Scholar 

  58. EASL. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237–67.

    Article  Google Scholar 

  59. Prince MI, Burt AD, Jones DE. Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut. 2002;50(3):436–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  60. Mayo MJ, Handem I, Saldana S, Jacobe H, Getachew Y, Rush AJ. Sertraline as a first-line treatment for cholestatic pruritus. Hepatology. 2007;45(3):666–74.

    Article  CAS  PubMed  Google Scholar 

  61. Bianchi G, Marchesini G, Nicolino F, Graziani R, Sgarbi D, Loguercio C, et al. Psychological status and depression in patients with liver cirrhosis. Digest Liver Dis: 2005;37(8):593–600.

    Article  CAS  Google Scholar 

  62. Montagnese S, De Pitta C, De Rui M, Corrias M, Turco M, Merkel C, et al. Sleep-wake abnormalities in patients with cirrhosis. Hepatology. 2014;59(2):705–12.

    Article  PubMed  Google Scholar 

  63. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120(1):170–8.

    Article  CAS  PubMed  Google Scholar 

  64. Hardy JR, Carmont SA, O’Shea A, Vora R, Schluter P, Nikles CJ, et al. Pilot study to determine the optimal dose of methylphenidate for an n-of-1 trial for fatigue in patients with cancer. J Palliat Med. 2010;13(10):1193–7.

    Article  PubMed  Google Scholar 

  65. Verne GN, Soldevia-Pico C, Robinson ME, Spicer KM, Reuben A. Autonomic dysfunction and gastroparesis in cirrhosis. J Clin Gastroenterol. 2004;38(1):72–6.

    Article  PubMed  Google Scholar 

  66. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003;124(7):1792–801.

    Article  CAS  PubMed  Google Scholar 

  67. Davis MP, Dickerson D. Cachexia and anorexia: cancer’s covert killer. Support Care Cancer. 2000;8(3):180–7.

    Article  CAS  PubMed  Google Scholar 

  68. Boyd K, Kimbell B, Murray S, Iredale J. Living and dying well with end-stage liver disease: time for palliative care? Hepatology. 2012;55(6):1650–1.

    Article  PubMed  Google Scholar 

  69. Rossaro L, Troppmann C, McVicar JP, Sturges M, Fisher K, Meyers FJ. A strategy for the simultaneous provision of pre-operative palliative care for patients awaiting liver transplantation. Transplant Int. 2004;17(8):473–5.

    Article  Google Scholar 

  70. O’Mahony S, McHenry J, Blank AE, Snow D, Eti Karakas S, Santoro G, et al. Preliminary report of the integration of a palliative care team into an intensive care unit. Palliat Med. 2010;24(2):154–65.

    Article  PubMed  Google Scholar 

  71. Parikh RB, Kirch RA, Smith TJ, Temel JS. Early specialty palliative care—translating data in oncology into practice. N Engl J Med. 2013;369(24):2347–51.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Transplant, Mayo Clinic, Mayo Clinic College of Medicine, Jacksonville, FL, USA

    Maria L. Yataco MD

  2. Department of Family Medicine, Mayo Clinic, Mayo Clinic College of Medicine, Jacksonville, FL, USA

    Robert Shannon MD, FAAHPM

  3. Department of Transplant, Mayo Clinic, Mayo Clinic College of Medicine, 4500 San Pablo Road, 32224, Jacksonville, FL, USA

    Andrew P. Keaveny MD, FRCPI

Authors
  1. Maria L. Yataco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Shannon MD, FAAHPM
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew P. Keaveny MD, FRCPI
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew P. Keaveny MD, FRCPI .

Editor information

Editors and Affiliations

  1. Department of Transplant, Mayo Clinic, Jacksonville, Florida, USA

    Andrew P. Keaveny

  2. Institut de Malalties Digestives i Metaboliques, University of Barcelona, Barcelona, Spain

    Andrés Cárdenas

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Yataco, M., Shannon, R., Keaveny, A. (2015). Palliative Care in Cirrhosis. In: Keaveny, A., Cárdenas, A. (eds) Complications of Cirrhosis. Springer, Cham. https://doi.org/10.1007/978-3-319-13614-1_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13614-1_35

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13613-4

  • Online ISBN: 978-3-319-13614-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation